argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
663.93
-20.57 (-3.01%)
At close: Mar 20, 2026, 4:00 PM EDT
677.09
+13.16 (1.98%)
After-hours: Mar 20, 2026, 6:23 PM EDT
argenx SE Market Cap
argenx SE has a market cap or net worth of $41.09 billion as of March 20, 2026. Its market cap has increased by 11.94% in one year.
Market Cap
41.09B
Enterprise Value
36.69B
1-Year Change
11.94%
Ranking
Category
Stock Price
$663.93
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $41.09B, an increase of 6,548.25%. That is a compound annual growth rate of 60.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 41.09B | -19.95% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 77.96B |
| Alnylam Pharmaceuticals | 41.26B |
| BeOne Medicines AG | 31.34B |
| Insmed | 31.04B |
| BioNTech SE | 22.45B |
| Moderna | 20.68B |
| Roivant Sciences | 19.90B |
| Revolution Medicines | 19.68B |